Regenerative medicine pioneer Andre Terzic, M.D., Ph.D., was named inaugural director of Mayo Clinic's Center for Regenerative Medicine on Jan. 4, 2011. [...]
Migraines affect nearly 40 million people in the U.S. Yet pinpointing an effective prophylactic medication ― the most commonly prescribed drugs for people diagnosed [...]
Mayo Clinic researchers have biomanufactured chimeric antigen receptor-T cell therapy (CAR-T cell therapy) in a new way to track the cells' cancer [...]
Preclinical studies discovered a cell-free bioactive material developed at Mayo Clinic triggered healing of one of the most common shoulder injuries. This Mayo [...]
Mayo Clinic researchers published a comprehensive analysis of the gut virome in Gastroenterology, showing how disease, diet and genomics interact with the gut virome [...]
In the last 15 days or so, COVID-19 related news continues to dominate the headlines on the research front. However, Mayo Clinic's expertise also was [...]
Regenerative neurosurgery is poised to transform care of neurological disorders that previously had little hope for improvement, according to a Mayo Clinic review [...]
— By Clarence Jones, a community research collaborator
-----------------
Editor’s note: Mayo Clinic advances health equity by engaging communities in research that addresses their health concerns and [...]
COVID-19 has once again taken almost all the headlines. However, research and expertise across the vastness of medicine still continues. Those stories are at the [...]
Mayo Clinic is preparing to advance a new era of health care by educating the regenerative medicine workforce of the future. Unique educational opportunities [...]